Lan Angela Li from Houston, TX, age 37

Address:

Boston, MA 02118

License #:

2245787 - Expired

Issued Date:

May 15, 2009

Expiration Date:

Jan 29, 2013

Type:

Cosmetologist Type 2

Liposomal Curcumin For Treatment Of Cancer
view source
US Patent:

7968115, Jun 28, 2011
Filed:

Sep 7, 2005
Appl. No.:

11/221179
Inventors:

Razelle Kurzrock - Houston TX, US
Lan Li - Houston TX, US
Kapil Mehta - Houston TX, US
Bharat Bhushan Aggarawal - Houston TX, US
Assignee:

Board of Regents, The University of Texas System - Austin TX
International Classification:

A61K 9/127
US Classification:

424450
Abstract:

The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.

Liposomal Curcumin For Treatment Of Neurofibromatosis
view source
US Patent:

20080103213, May 1, 2008
Filed:

Oct 5, 2007
Appl. No.:

11/868251
Inventors:

RAZELLE KURZROCK - HOUSTON TX, US
LAN LI - HOUSTON TX, US
KAPIL MEHTA - HOUSTON TX, US
BHARAT AGGARWAL - HOUSTON TX, US
Assignee:

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:

A61K 31/12
A61P 25/00
US Classification:

514679000
Abstract:

The present invention provides a compositions and methods for the treatment of Neurofibromatosis Type 1 and 2, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system to target Merlin and proteins of the Merlin pathway. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.

Liposomal Curcumin For Treatment Of Diseases
view source
US Patent:

20080138400, Jun 12, 2008
Filed:

Dec 1, 2007
Appl. No.:

11/949027
Inventors:

RAZELLE KURZROCK - Bellaire TX, US
LAN LI - HOUSTON TX, US
KAPIL MEHTA - Bellaire TX, US
BHARAT BHUSHAN AGGARAWAL - HOUSTON TX, US
LAWRENCE HELSON - Quakertown PA, US
Assignee:

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:

A61K 9/127
A61K 31/12
A61P 35/04
A61P 29/00
A61P 37/00
A61P 25/00
A61P 19/00
A61P 1/00
US Classification:

424450, 514679
Abstract:

The present invention provides compositions and methods for the treatment of a human patient. The methods and compositions of the present invention include composition for the efficient loading of curcumin, comprising: an amount of a curcuminoid:liposome complex effective to load curcumin into the liposome, wherein the curcuminoids has between 2 to 9 weight percent of the total composition and the curcuminoids are natural or synthetic.

Liposomal Curcumin For Treatment Of Cancer
view source
US Patent:

20110287085, Nov 24, 2011
Filed:

May 27, 2011
Appl. No.:

13/117807
Inventors:

Razelle Kurzrock - Houston TX, US
Lan Li - Houston TX, US
Kapil Mehta - Houston TX, US
Bharat B. Aggarwal - Houston TX, US
Assignee:

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:

A61K 9/14
A61P 35/00
A61K 9/51
A61K 9/19
A61K 31/12
A61K 9/127
US Classification:

424450, 424489, 514679, 424501, 424451
Abstract:

The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.

Liposomal Curcumin For Treatment Of Cancer
view source
US Patent:

20160193159, Jul 7, 2016
Filed:

Mar 14, 2016
Appl. No.:

15/069413
Inventors:

- Austin TX, US
Lan Li - Houston TX, US
Kapil Mehta - Bellaire TX, US
Bharat Aggarwal - Houston, US
International Classification:

A61K 31/12
A61K 9/127
Abstract:

The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.